These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26172085)

  • 1. The epitope analysis of an antibody specifically against Vibrio cholerae O1 Ogawa by phage library study.
    Cheng S; Lin Z; Liu X; Zheng W; Lu G; Tu Z; Zhang J; Zheng J; Yu X
    J Microbiol Methods; 2015 Oct; 117():22-7. PubMed ID: 26172085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
    Kim D; Hong J; Choi Y; Han J; Kim S; Jo G; Yoon JY; Chae H; Yoon H; Lee C; Hong HJ
    J Microbiol Biotechnol; 2020 Nov; 30(11):1760-1768. PubMed ID: 32876069
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.
    Dharmasena MN; Krebs SJ; Taylor RK
    Microbiology (Reading); 2009 Jul; 155(Pt 7):2353-2364. PubMed ID: 19389772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of lipopolysaccharide-mimicking peptides and their immunoprotectivity against Vibrio cholerae serogroup O1.
    Mohammad Pour Ghazi F; Gargari SL
    J Pept Sci; 2016 Nov; 22(11-12):682-688. PubMed ID: 27766741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.
    Dharmasena MN; Jewell DA; Taylor RK
    J Biol Chem; 2007 Nov; 282(46):33805-33816. PubMed ID: 17881351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of
    Kauffman RC; Adekunle O; Yu H; Cho A; Nyhoff LE; Kelly M; Harris JB; Bhuiyan TR; Qadri F; Calderwood SB; Charles RC; Ryan ET; Kong J; Wrammert J
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879588
    [No Abstract]   [Full Text] [Related]  

  • 8. Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains.
    Wade TK; Wade WF
    Microbiol Immunol; 2008 Dec; 52(12):611-20. PubMed ID: 19120975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
    Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ
    J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches.
    Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y
    Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin.
    Tamplin ML; Ahmed MK; Jalali R; Colwell RR
    J Gen Microbiol; 1989 May; 135(5):1195-200. PubMed ID: 2482860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an immunochromatographic lateral flow device for rapid diagnosis of Vibrio cholerae O1 serotype Ogawa.
    Chen W; Zhang J; Lu G; Yuan Z; Wu Q; Li J; Xu G; He A; Zheng J; Zhang J
    Clin Biochem; 2014 Apr; 47(6):448-54. PubMed ID: 24389075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of mouse monoclonal antibodies against Helicobacter pylori Lpp20 and mapping the antigenic epitope by phage display library.
    Li Y; Ning YS; Wang YD; Hong YH; Luo J; Dong WQ; Li M
    J Immunol Methods; 2007 Aug; 325(1-2):1-8. PubMed ID: 17658545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.
    Pérez JL; Acevedo R; Callicó A; Fernández Y; Cedré B; Año G; González L; Falero G; Talavera A; Pérez O; García L
    Vaccine; 2009 Jan; 27(2):205-12. PubMed ID: 18996426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epitope identification of monoclonal antibody 5C6 against 14-3-3 protein of Schistosoma japonicum].
    Qian CY; Song LJ; Yu CX; Yin XR; Wang J; Zhang W; Jin Y; Ke XD
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Feb; 24(1):45-9. PubMed ID: 22590863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selecting the phage displaying tetrodotoxin mimic epitope by phage random peptide library].
    Zhang L; Jiang T; Ji R
    Wei Sheng Yan Jiu; 2010 May; 39(3):299-301, 305. PubMed ID: 20568457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.